
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-08-03-2016
- Volume 11
- Issue 8
Recipharm Expands Blow-Fill-Seal Capacity at France Facility
The company will invest €18 million in its Kaysersberg facility to expand blow-fill-seal capacity.
On July 5, 2016, Recipharm announced that the company will invest €18 million (approximately $19.73) to expand blow-fill-seal (BFS) capacity at its site in Kaysersberg, France. The investment will include the introduction of a BFS high-speed filling and packaging line, Recipharm said in a press announcement. Recihparm’s Kaysersberg site is a sterile facility specializing in BFS technology for sterile liquids.
Recipharm says it will also prepare to add three additional filling lines to the facility in upcoming years, increasing the company’s BFS capacity by 50%. Yves Buelens, general manager of the Kaysersberg site, said the company is experiencing increased demand for BFS services. “We are experiencing increased demand for our blow-fill-seal services from markets including the United States, Turkey, Australia, and Canada, and the new filling line will help us to meet this growing need,” Buelens noted in a press announcement.
Source: Recipharm
Articles in this issue
over 9 years ago
Slower Bio/Pharma Investment Could Hurt CDMOs in 2017over 9 years ago
Supply Chain Partner Scrutiny Moves Beyond GMPsover 9 years ago
Chiral Advances Demonstrate Promise for API Synthesisover 9 years ago
NIST Issues mAb Reference Standardover 9 years ago
EMA Suspends Drugs Due to Flawed Bioequivalence Studiesover 9 years ago
CordenPharma Expands into Oligonucleotide APIsover 9 years ago
Shimadzu System Combines HPLC and UHPLC Methodsover 9 years ago
Catalent to Commercially Supply Palatin FSD Pen Injectorsover 9 years ago
Zenith Appoints Serialization DirectorNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.




